From: Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma
Variables | Overall survival (d) mean (95 % CI) | p |
---|---|---|
BMI | 3.6 × 10−13 | |
<23 kg/m2 | 353.9 (316.9–391.0) | |
≥23 kg/m2 | 571.8 (532.3–611.4) | |
Age | 0.924 | |
<60 years | 444.9 (397.6–492.1) | |
≥60 years | 444.2 (406.8–481.5) | |
Gender | 0.537 | |
Male | 451.9 (413.7–490.2) | |
Female | 427.2 (382.8–471.6) | |
Diabetes | 0.563 | |
Yes | 440.6 (408.3–474.0) | |
No | 457.2 (388.0–526.5) | |
Alcohol | 0.453 | |
Ever | 425.8 (369.4–482.1) | |
Never | 451.4 (417.1–485.6) | |
Smoking | 0.085 | |
Ever | 411.6 (362.2–461.1) | |
Never | 462.1 (425.9–498.3) | |
AFP | 0.651 | |
≥400 μg/L | 456.8 (405.2–508.4) | |
<400 μg/L | 433.7 (396.3–471.1) | |
Viral status | 0.349 | |
HBV | 432.8 (396.0–469.6) | |
HCV | 459.8 (408.3–511.3) | |
Previous treatment | 0.502 | |
Yes | 459.8 (405.3–514.3) | |
No | 432.7 (396.9–468.5) | |
Child–Pugh class | 3.6 × 10−31 | |
A class | 627.1 (592.0–662.2) | |
B class | 479.7 (435.0–524.5) | |
C class | 232.0 (198.9–265.2) | |
Extrahepatic metastasis | 5.3 × 10−13 | |
Yes | 202.4 (148.4–256.4) | |
No | 471.2 (440.7–501.7) | |
Infiltration of portal vein | 1.4 × 10−13 | |
Yes | 259.9 (228.0–290.8) | |
No | 513.2 (479.2–547.1) | |
Treatment after diagnosis | 2.5 × 10–31 | |
Yes | 617.2 (589.2–645.2) | |
No | 259.7 (232.5–286.9) | |
BCLC stage | 1.4 × 10−36 | |
0 stage | 696.3 (652.7–739.8) | |
1 stage | 678.8 (653.2–704.4) | |
2 stage | 544.8 (500.2–589.4) | |
3 stage | 299.6 (257.9–341.2) | |
4 stage | 232.0 (198.9–265.2) |